FOLFOXIRI vs FOLFIRINOX as first-line chemotherapy in patients with advanced pancreatic cancer: A population-based cohort study
暂无分享,去创建一个
C. Borg | E. Gherga | Thierry Nguyen | D. Vernerey | Stefano Kim | F. Fein | E. Klajer | F. Calcagno | A. Meurisse | M. Jary | H. Almotlak | A. Turpin | S. Abdeljaoued | A. Vienot | M. Nasri | H. Chevalier | C. D'engremont | C. Bolognini | Syrine Abdeljaoued